As of 2023, countries like Costa Rica, Croatia, Argentina, and Finland boast a 100% global share of corresponding/leading authorship in scientific publications related to complementary and manual therapy. Not far behind, South Korean scholars lead with a 99.77% share, followed by Spain and India with 98.13% and 97.68%, respectively. Larger academic markets such as the United States and China reported lower percentages at 95.98% and 93.59%. Meanwhile, Chile's share at 32% stands out as exceptionally low in comparison. The data presents varied performance across nations in this field, reflecting diverse levels of scholarly engagement.
Key future trends to watch include:
- Potential growth in countries below the 90% mark, such as Canada, Egypt, and Indonesia, as they increase investment in academic and research capabilities.
- Critical continuous monitoring to assess how countries with above 90% share sustain their influence amidst global academic collaboration.
- Impacts of emerging technologies and methodologies on publication dynamics, potentially altering the geographic distribution of lead authorship.
Top countries in Share of Corresponding/Leading Author in Scientific Publications in Complementary and Manual Therapy by Country
| # | 10 Countries | Percent | Last Year | |
|---|---|---|---|---|
| 1 | 1 Costa Rica | 100 | 2021 | View data |
| 2 | 2 Croatia | 100 | 2021 | View data |
| 3 | 3 Argentina | 100 | 2021 | View data |
| 4 | 4 Finland | 100 | 2021 | View data |
| 5 | 5 Mexico | 100 | 2021 | View data |
| 6 | 6 South Korea | 99.77 | 2023 | View data |
| 7 | 7 Spain | 98.13 | 2023 | View data |
| 8 | 8 India | 97.68 | 2023 | View data |
| 9 | 9 Germany | 97.43 | 2023 | View data |
| 10 | 10 Brazil | 97.16 | 2023 | View data |
Latest reports
US Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the US pharmaceuticals market exhibited robust growth across various segments, driven by strategic investments, regulatory advancements, and...
Japan Pharmaceuticals Market Report- Q4 2024
The Japanese pharmaceutical industry in Q4 2024 exhibits dynamic shifts driven by government policies, market demand, and strategic innovations. The continuous rise of...
Germany Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presented a multifaceted landscape for the German pharmaceuticals industry, characterized by economic pressures, regulatory changes, and evolving consumer...
India Pharmaceuticals Market Report- Q4 2024
The Indian pharmaceutical industry in Q4 2024 continues to show dynamic growth, fueled by advancements in biologics and biosimilars, substantial export activities, and...
UK Pharmaceuticals Market Report- Q4 2024
The UK Pharmaceuticals market in Q4 2024 faced a dynamic landscape shaped by economic, regulatory, and competitive factors. Amidst inflationary pressures and evolving...
France Pharmaceuticals Market Report- Q4 2024
The French pharmaceuticals market in the fourth quarter of 2024 was marked by significant developments across various segments, including biopharmaceuticals, generic drugs, over-the-counter...
Canada Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the Canadian pharmaceuticals market showcased dynamic growth and adaptation across various segments. The evolving landscape was influenced...
Brazil Pharmaceuticals Market Report- Q4 2024
The Brazil pharmaceuticals market in Q4 2024 is characterized by significant trends and strategic developments across various segments. The demand for generic pharmaceuticals...
Italy Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic landscape for the pharmaceuticals market in Italy, characterized by significant trends and strategic developments across...
South Korea Pharmaceuticals Market Report- Q1 2025
The first quarter of 2025 has been pivotal for the pharmaceuticals industry in South Korea, marked by significant growth in the biopharmaceuticals and...